BOCA RATON, Fla., Oct. 14, 2004 (PRIMEZONE) -- Pure H2O Bio-Technologies, Inc., (Pink Sheets:PHBT) announced today it received final reports confirming laboratory test data performed for them by Clancy Environmental Consultants (CEC), a nationally recognized microbiological/water expert, located in St. Albans, Vermont, on the efficacy of iodine at low concentrations on three major waterborne bacterial contaminants. These included Escherichia coli, Enterococcus faecalis, and Pseudomonas aeruginosa. Treatment with low concentrations reduced the number of microbes by approximately 6 logs (99.9999% killed) within 5 minutes and 8 logs (99.999999% killed) within 10 minutes. This means that a concentration of more than 1 million bacteria were killed within these time periods by this disinfectant. The PHBT system is designed to kill microbes and remove iodine from the water, thereby yielding water free of both the disinfectant and microbes to the consumer. CEC has served the United States Environmental Protection Agency (EPA), American Waterworks Association (AWA) and private industry in an advisory and consultant capacity. Joseph P. Doxey, President of PHBT stated, "We are confident using Iodine as the preferred disinfectant because we have additional definitive raw data regarding iodine at low levels." Further evaluations, including quality assurance (disinfection and water purification) of PHBT's systems are to be managed by US Biosystems, another nationally recognized environmental laboratory located in Boca Raton, Florida, USA.
Consumer Knowledge and Awareness:
Log 10 = Log base 10 is the number raised to the power of 10. Example: 10(1) = 10; 10(2) = 100; etc. and log reduction of 1= 90% reduction in the number, log of 2 = 99% reduction, and of log 3 = 99.9% reduction, etc. 6 log reduction means 1,000,000 killed 8 log reduction means 100,000,000 killed
The Company: PHBT is a publicly-held company specializing in the manufacture, design and sale of its unique residential, commercial and hospital water disinfection systems that combat waterborne disease.
The foregoing press release contains forward- looking statements that can be identified by such terminology as "expects," potential, "suggests," "may," will," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. IN particular, management's expectations regarding future research, development, and or commercial results could be affected by, among other things, uncertainties relating to the availability of future financing; unexpected regulatory delays or government regulation generally; the company's ability to obtain or maintain patent and other proprietary intellectual property protection; and competition in general. Forward-looking statements speak only as to the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.